End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11.9 CNY | +2.50% | -7.61% | -27.88% |
Valuation
Fiscal Period: December | 2023 |
---|---|
Capitalization 1 | 5,883 |
Enterprise Value (EV) 1 | 4,900 |
P/E ratio | 56.9 x |
Yield | 0.61% |
Capitalization / Revenue | 10.1 x |
EV / Revenue | 8.42 x |
EV / EBITDA | 46.7 x |
EV / FCF | 119 x |
FCF Yield | 0.84% |
Price to Book | 3.99 x |
Nbr of stocks (in thousands) | 356,554 |
Reference price 2 | 16.50 |
Announcement Date | 24-04-23 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Net sales 1 | 439.4 | 489.6 | 547.1 | 581.7 |
EBITDA 1 | 91.22 | 91.42 | 106 | 104.9 |
EBIT 1 | 62.8 | 61.89 | 75.4 | 79.02 |
Operating Margin | 14.29% | 12.64% | 13.78% | 13.58% |
Earnings before Tax (EBT) 1 | 62.42 | 78.94 | 88.07 | 96.8 |
Net income 1 | 50.72 | 70.22 | 78.98 | 85.63 |
Net margin | 11.54% | 14.34% | 14.44% | 14.72% |
EPS 2 | 0.2131 | 0.2700 | 0.3000 | 0.2900 |
Free Cash Flow 1 | -8.338 | 91.88 | 47.36 | 41.17 |
FCF margin | -1.9% | 18.77% | 8.66% | 7.08% |
FCF Conversion (EBITDA) | - | 100.51% | 44.69% | 39.24% |
FCF Conversion (Net income) | - | 130.84% | 59.96% | 48.07% |
Dividend per Share | - | - | - | 0.1000 |
Announcement Date | 23-08-10 | 23-08-10 | 23-08-10 | 24-04-23 |
Balance Sheet Analysis
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Net Debt 1 | - | - | - | - |
Net Cash position 1 | 136 | 252 | 122 | 983 |
Leverage (Debt/EBITDA) | - | - | - | - |
Free Cash Flow 1 | -8.34 | 91.9 | 47.4 | 41.2 |
ROE (net income / shareholders' equity) | 13% | 14.6% | 14.2% | 8.29% |
ROA (Net income/ Total Assets) | 6.45% | 5.68% | 6.52% | 4.09% |
Assets 1 | 785.7 | 1,236 | 1,212 | 2,092 |
Book Value Per Share 2 | 1.880 | 1.980 | 2.220 | 4.130 |
Cash Flow per Share 2 | 0.2300 | 0.0900 | 0.1800 | 1.200 |
Capex 1 | 7.31 | 25.6 | 26.9 | 36.1 |
Capex / Sales | 1.66% | 5.22% | 4.92% | 6.2% |
Announcement Date | 23-08-10 | 23-08-10 | 23-08-10 | 24-04-23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-27.88% | 586M | |
+45.82% | 765B | |
+40.95% | 632B | |
-6.16% | 354B | |
+19.86% | 331B | |
+9.32% | 299B | |
+18.45% | 248B | |
-0.78% | 219B | |
+11.88% | 216B | |
+5.90% | 164B |
- Stock Market
- Equities
- 301507 Stock
- Financials Hangzhou Minsheng Healthcare Co., Ltd.